ETFs
C
IPSC
Century Therapeutics, Inc.
1.655
+0.185+12.59%Opening13:01 10/20 EDT
OPEN/PREV CLOSE1.490/1.470
TODAY RANGE1.400-1.745
VOL729.81K
MARKET CAP299.68M
52 WEEK RANGE0.4350-3.040
AVG VOL (3M)607.43K
% TURNOVER0.40%
TURNOVER--
P/E (TTM)-1.8440
% RANGE23.46%
EPS(TTM)-0.8975
P/E(FORWARD)-3.1524
P/B1.286
BVPS1.287
DIVIDEND--
P/S1.327
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP275.24M
SHARES OUTSTANDING181.08M
NEXT EARNINGS11/11-11/16
FREE FLOAT166.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10/02 12:48
Century Therapeutics advances CNTY-813 islet therapy program
TipRanks·10/02 12:15
Century Therapeutics announces presentation of nonclinical data for CNTY-813
Benzinga·10/02 12:07
Century Therapeutics Presents CNTY-813 Nonclinical Data At EASD 2026
Seeking Alpha·09/30 08:27
Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet
TipRanks·09/09 20:31
Century Therapeutics Adds Director, Advances Cell Therapy Pipeline
Dow Jones·09/09 20:05
Press Release: Century Therapeutics Appoints Joseph Truitt to Board of Directors
Dow Jones·09/09 20:05
*Century Therapeutics Appoints Joseph Truitt to Bd of Directors
TipRanks·08/17 16:15
Century Therapeutics (IPSC) Gets a Buy from Mizuho Securities
TipRanks·08/13 07:18
Clear Street Sticks to Its Buy Rating for Century Therapeutics (IPSC)
NASDAQ·08/12 18:02
Century Advances CNTY-813; IND Submission On Track For Q4 2026
TipRanks·08/12 12:48
Century Therapeutics Reports Q2 Results, Pipeline Advancements
Same Industry
Name/Symbol
Change%
Price